Do analysts recommend NEPH or CUPR?

Nephros currently has a consensus price target of $4.00, suggesting a potential upside of 13.64%. Given Nephros' stronger consensus rating and higher possible upside, research analysts plainly believe Nephros is more favorable than Cuprina Holdings (Cayman). Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nephros 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25 Cuprina Holdings (Cayman) 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings & valuation, NEPH or CUPR?

Nephros has higher revenue and earnings than Cuprina Holdings (Cayman). Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Nephros $18.79M 2.03 $1.19M $0.16 22.00 Cuprina Holdings (Cayman) $40K 348.25 -$3.63M N/A N/A

Do analysts prefer CUPR or RMTI?

Rockwell Medical has a consensus target price of $20.00, suggesting a potential upside of 161.10%. Given Rockwell Medical's stronger consensus rating and higher probable upside, analysts plainly believe Rockwell Medical is more favorable than Cuprina Holdings (Cayman). Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cuprina Holdings (Cayman) 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Rockwell Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has higher earnings and valuation, CUPR or RMTI?

Cuprina Holdings (Cayman) has higher earnings, but lower revenue than Rockwell Medical. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cuprina Holdings (Cayman) $40K 348.25 -$3.63M N/A N/A Rockwell Medical $69.26M 0.45 -$5.31M -$1.34 N/A

Do analysts prefer RVP or CUPR?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Retractable Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Cuprina Holdings (Cayman) 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings & valuation, RVP or CUPR?

Cuprina Holdings (Cayman) has lower revenue, but higher earnings than Retractable Technologies. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Retractable Technologies $33.90M 0.52 -$7.01M -$0.12 N/A Cuprina Holdings (Cayman) $40K 348.25 -$3.63M N/A N/A

Do analysts prefer CUPR or LUCY?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cuprina Holdings (Cayman) 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Innovative Eyewear 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Which has stronger earnings and valuation, CUPR or LUCY?

Cuprina Holdings (Cayman) has higher earnings, but lower revenue than Innovative Eyewear. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cuprina Holdings (Cayman) $40K 348.25 -$3.63M N/A N/A Innovative Eyewear $2.66M 2.73 -$7.59M -$1.29 N/A

Do analysts prefer BMRA or CUPR?

Biomerica presently has a consensus price target of $9.00, suggesting a potential upside of 397.24%. Given Biomerica's higher possible upside, equities research analysts plainly believe Biomerica is more favorable than Cuprina Holdings (Cayman). Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biomerica 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Cuprina Holdings (Cayman) 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation and earnings, BMRA or CUPR?

Cuprina Holdings (Cayman) has lower revenue, but higher earnings than Biomerica. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Biomerica $4.45M 1.26 -$3.78M -$1.27 N/A Cuprina Holdings (Cayman) $40K 348.25 -$3.63M N/A N/A

Cuprina Holdings (Cayman) (CUPR) Competitors

$1.99 +0.09 (+4.74%)

Closing price 10/14/2026 04:00 PM Eastern

Extended Trading

$1.99 0.00 (0.00%)

As of 06:10 AM Eastern

Compare

CUPR vs. NEPH, RMTI, RVP, LUCY, and BMRA

Should you buy Cuprina Holdings (Cayman) stock or one of its competitors? Cuprina Holdings (Cayman)'s main competitors and comparable companies include Nephros (NEPH), Rockwell Medical (RMTI), Retractable Technologies (RVP), Innovative Eyewear (LUCY), and Biomerica (BMRA). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does Cuprina Holdings (Cayman) compare to Nephros?

Nephros (NASDAQ:NEPH) and Cuprina Holdings (Cayman) (NASDAQ:CUPR) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, risk, analyst recommendations and media sentiment.

Nephros has a net margin of 8.38% compared to Cuprina Holdings (Cayman)'s net margin of 0.00%. Nephros' return on equity of 10.60% beat Cuprina Holdings (Cayman)'s return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nephros	8.38%	10.60%	8.05%
Cuprina Holdings (Cayman)	N/A	N/A	N/A

Nephros currently has a consensus price target of $4.00, suggesting a potential upside of 13.64%. Given Nephros' stronger consensus rating and higher possible upside, research analysts plainly believe Nephros is more favorable than Cuprina Holdings (Cayman).

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nephros	0 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.25
Cuprina Holdings (Cayman)	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Nephros has higher revenue and earnings than Cuprina Holdings (Cayman).

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nephros	$18.79M	2.03	$1.19M	$0.16	22.00
Cuprina Holdings (Cayman)	$40K	348.25	-$3.63M	N/A	N/A

41.1% of Nephros shares are held by institutional investors. 6.7% of Nephros shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Nephros has a beta of 1.64, indicating that its stock price is 64% more volatile than the broader market. Comparatively, Cuprina Holdings (Cayman) has a beta of -0.1, indicating that its stock price is 110% less volatile than the broader market.

In the previous week, Nephros had 2 more articles in the media than Cuprina Holdings (Cayman). MarketBeat recorded 3 mentions for Nephros and 1 mentions for Cuprina Holdings (Cayman). Cuprina Holdings (Cayman)'s average media sentiment score of 1.79 beat Nephros' score of 0.70 indicating that Cuprina Holdings (Cayman) is being referred to more favorably in the news media.

Company	Overall Sentiment
Nephros	Positive
Cuprina Holdings (Cayman)	Very Positive

Summary

Nephros beats Cuprina Holdings (Cayman) on 12 of the 14 factors compared between the two stocks.

How does Cuprina Holdings (Cayman) compare to Rockwell Medical?

Cuprina Holdings (Cayman) (NASDAQ:CUPR) and Rockwell Medical (NASDAQ:RMTI) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, earnings, media sentiment, analyst recommendations, risk, dividends, institutional ownership and profitability.

In the previous week, Rockwell Medical had 2 more articles in the media than Cuprina Holdings (Cayman). MarketBeat recorded 3 mentions for Rockwell Medical and 1 mentions for Cuprina Holdings (Cayman). Cuprina Holdings (Cayman)'s average media sentiment score of 1.79 beat Rockwell Medical's score of 0.40 indicating that Cuprina Holdings (Cayman) is being referred to more favorably in the media.

Company	Overall Sentiment
Cuprina Holdings (Cayman)	Very Positive
Rockwell Medical	Neutral

Rockwell Medical has a consensus target price of $20.00, suggesting a potential upside of 161.10%. Given Rockwell Medical's stronger consensus rating and higher probable upside, analysts plainly believe Rockwell Medical is more favorable than Cuprina Holdings (Cayman).

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cuprina Holdings (Cayman)	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Rockwell Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Cuprina Holdings (Cayman) has higher earnings, but lower revenue than Rockwell Medical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cuprina Holdings (Cayman)	$40K	348.25	-$3.63M	N/A	N/A
Rockwell Medical	$69.26M	0.45	-$5.31M	-$1.34	N/A

Cuprina Holdings (Cayman) has a beta of -0.1, meaning that its share price is 110% less volatile than the broader market. Comparatively, Rockwell Medical has a beta of 1.63, meaning that its share price is 63% more volatile than the broader market.

23.3% of Rockwell Medical shares are held by institutional investors. 4.6% of Rockwell Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Cuprina Holdings (Cayman) has a net margin of 0.00% compared to Rockwell Medical's net margin of -7.33%. Cuprina Holdings (Cayman)'s return on equity of 0.00% beat Rockwell Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cuprina Holdings (Cayman)	N/A	N/A	N/A
Rockwell Medical	-7.33%	-14.03%	-8.90%

Summary

Rockwell Medical beats Cuprina Holdings (Cayman) on 8 of the 14 factors compared between the two stocks.

How does Cuprina Holdings (Cayman) compare to Retractable Technologies?

Retractable Technologies (NYSE:RVP) and Cuprina Holdings (Cayman) (NASDAQ:CUPR) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, media sentiment, analyst recommendations, valuation and risk.

Retractable Technologies has a beta of 1.2, indicating that its stock price is 20% more volatile than the broader market. Comparatively, Cuprina Holdings (Cayman) has a beta of -0.1, indicating that its stock price is 110% less volatile than the broader market.

Cuprina Holdings (Cayman) has lower revenue, but higher earnings than Retractable Technologies.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Retractable Technologies	$33.90M	0.52	-$7.01M	-$0.12	N/A
Cuprina Holdings (Cayman)	$40K	348.25	-$3.63M	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Cuprina Holdings (Cayman)	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

7.6% of Retractable Technologies shares are held by institutional investors. 59.5% of Retractable Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Cuprina Holdings (Cayman) has a net margin of 0.00% compared to Retractable Technologies' net margin of -41.11%. Cuprina Holdings (Cayman)'s return on equity of 0.00% beat Retractable Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Retractable Technologies	-41.11%	-17.15%	-9.33%
Cuprina Holdings (Cayman)	N/A	N/A	N/A

In the previous week, Cuprina Holdings (Cayman) had 1 more articles in the media than Retractable Technologies. MarketBeat recorded 1 mentions for Cuprina Holdings (Cayman) and 0 mentions for Retractable Technologies. Cuprina Holdings (Cayman)'s average media sentiment score of 1.79 beat Retractable Technologies' score of 0.00 indicating that Cuprina Holdings (Cayman) is being referred to more favorably in the news media.

Company	Overall Sentiment
Retractable Technologies	Neutral
Cuprina Holdings (Cayman)	Very Positive

Summary

Cuprina Holdings (Cayman) beats Retractable Technologies on 8 of the 12 factors compared between the two stocks.

How does Cuprina Holdings (Cayman) compare to Innovative Eyewear?

Cuprina Holdings (Cayman) (NASDAQ:CUPR) and Innovative Eyewear (NASDAQ:LUCY) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, profitability, media sentiment, valuation, analyst recommendations, dividends and institutional ownership.

Cuprina Holdings (Cayman) has a beta of -0.1, meaning that its stock price is 110% less volatile than the broader market. Comparatively, Innovative Eyewear has a beta of 2.74, meaning that its stock price is 174% more volatile than the broader market.

Cuprina Holdings (Cayman) has a net margin of 0.00% compared to Innovative Eyewear's net margin of -225.26%. Cuprina Holdings (Cayman)'s return on equity of 0.00% beat Innovative Eyewear's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cuprina Holdings (Cayman)	N/A	N/A	N/A
Innovative Eyewear	-225.26%	-88.90%	-80.34%

1.0% of Innovative Eyewear shares are owned by institutional investors. 1.8% of Innovative Eyewear shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cuprina Holdings (Cayman)	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Innovative Eyewear	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

In the previous week, Innovative Eyewear had 2 more articles in the media than Cuprina Holdings (Cayman). MarketBeat recorded 3 mentions for Innovative Eyewear and 1 mentions for Cuprina Holdings (Cayman). Cuprina Holdings (Cayman)'s average media sentiment score of 1.79 beat Innovative Eyewear's score of 0.50 indicating that Cuprina Holdings (Cayman) is being referred to more favorably in the media.

Company	Overall Sentiment
Cuprina Holdings (Cayman)	Very Positive
Innovative Eyewear	Positive

Cuprina Holdings (Cayman) has higher earnings, but lower revenue than Innovative Eyewear.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cuprina Holdings (Cayman)	$40K	348.25	-$3.63M	N/A	N/A
Innovative Eyewear	$2.66M	2.73	-$7.59M	-$1.29	N/A

Summary

Cuprina Holdings (Cayman) and Innovative Eyewear tied by winning 6 of the 12 factors compared between the two stocks.

How does Cuprina Holdings (Cayman) compare to Biomerica?

Biomerica (NASDAQ:BMRA) and Cuprina Holdings (Cayman) (NASDAQ:CUPR) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, media sentiment, profitability, risk, institutional ownership and analyst recommendations.

In the previous week, Biomerica had 2 more articles in the media than Cuprina Holdings (Cayman). MarketBeat recorded 3 mentions for Biomerica and 1 mentions for Cuprina Holdings (Cayman). Cuprina Holdings (Cayman)'s average media sentiment score of 1.79 beat Biomerica's score of 0.84 indicating that Cuprina Holdings (Cayman) is being referred to more favorably in the news media.

Company	Overall Sentiment
Biomerica	Positive
Cuprina Holdings (Cayman)	Very Positive

Biomerica has a beta of 0.38, indicating that its share price is 62% less volatile than the broader market. Comparatively, Cuprina Holdings (Cayman) has a beta of -0.1, indicating that its share price is 110% less volatile than the broader market.

22.3% of Biomerica shares are owned by institutional investors. 18.0% of Biomerica shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Biomerica presently has a consensus price target of $9.00, suggesting a potential upside of 397.24%. Given Biomerica's higher possible upside, equities research analysts plainly believe Biomerica is more favorable than Cuprina Holdings (Cayman).

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biomerica	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Cuprina Holdings (Cayman)	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Cuprina Holdings (Cayman) has a net margin of 0.00% compared to Biomerica's net margin of -84.79%. Cuprina Holdings (Cayman)'s return on equity of 0.00% beat Biomerica's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biomerica	-84.79%	-97.19%	-61.57%
Cuprina Holdings (Cayman)	N/A	N/A	N/A

Cuprina Holdings (Cayman) has lower revenue, but higher earnings than Biomerica.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biomerica	$4.45M	1.26	-$3.78M	-$1.27	N/A
Cuprina Holdings (Cayman)	$40K	348.25	-$3.63M	N/A	N/A

Summary

Biomerica and Cuprina Holdings (Cayman) tied by winning 6 of the 12 factors compared between the two stocks.

Get Cuprina Holdings (Cayman) News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CUPR vs. The Competition

Export

Metric	Cuprina Holdings (Cayman)	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$13.31M	$5.59B	$7.19B	$13.18B
Dividend Yield	N/A	1.74%	2.52%	19.59%
P/E Ratio	N/A	21.32	223.62	21.16
Price / Sales	279.35	65.09	547.34	66.59
Price / Cash	N/A	32.11	76.68	52.75
Price / Book	1.33	5.72	10.22	5.92
Net Income	-$3.63M	$146.93M	$3.50B	$380.90M
7 Day Performance	4.74%	-1.61%	-3.50%	-3.90%
1 Month Performance	-32.08%	-4.38%	-7.78%	-6.42%
1 Year Performance	N/A	0.69%	0.79%	-6.02%

Cuprina Holdings (Cayman) Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CUPR Cuprina Holdings (Cayman)	0.8873 of 5 stars	$1.99 +4.7%	N/A	N/A	$13.31M	$49.89K	N/A	10	Positive News Analyst Downgrade Gap Down
NEPH Nephros	3.9933 of 5 stars	$3.20 +6.0%	$4.00 +25.0%	-34.6%	$32.80M	$18.79M	20.00	36	News Coverage Short Interest Decrease
RMTI Rockwell Medical	3.3647 of 5 stars	$8.22 +7.5%	$20.00 +143.3%	-36.2%	$30.83M	$69.26M	N/A	157	News Coverage High Trading Volume
RVP Retractable Technologies	N/A	$0.69 0.0%	N/A	-35.3%	$20.68M	$33.90M	N/A	201
LUCY Innovative Eyewear	0.5262 of 5 stars	$0.91 -1.4%	N/A	-56.0%	$8.06M	$2.66M	N/A	13

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CUPR) was last updated on 10/15/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cuprina Holdings (Cayman) (CUPR) Competitors

CUPR vs. NEPH, RMTI, RVP, LUCY, and BMRA

How does Cuprina Holdings (Cayman) compare to Nephros?

Summary

How does Cuprina Holdings (Cayman) compare to Rockwell Medical?

Summary

How does Cuprina Holdings (Cayman) compare to Retractable Technologies?

Summary

How does Cuprina Holdings (Cayman) compare to Innovative Eyewear?

Summary

How does Cuprina Holdings (Cayman) compare to Biomerica?

Summary

Media Sentiment Over Time

CUPR vs. The Competition

Cuprina Holdings (Cayman) Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cuprina Holdings (Cayman) (CUPR) Competitors

CUPR vs. NEPH, RMTI, RVP, LUCY, and BMRA

How does Cuprina Holdings (Cayman) compare to Nephros?

Is NEPH or CUPR more profitable?

Do analysts recommend NEPH or CUPR?

Which has preferable earnings & valuation, NEPH or CUPR?

Do institutionals & insiders hold more shares of NEPH or CUPR?

Which has more volatility & risk, NEPH or CUPR?

Does the media refer more to NEPH or CUPR?

Summary

How does Cuprina Holdings (Cayman) compare to Rockwell Medical?

Does the media favor CUPR or RMTI?

Do analysts prefer CUPR or RMTI?

Which has higher earnings and valuation, CUPR or RMTI?

Which has more risk and volatility, CUPR or RMTI?

Do institutionals and insiders believe in CUPR or RMTI?

Is CUPR or RMTI more profitable?

Summary

How does Cuprina Holdings (Cayman) compare to Retractable Technologies?

Which has more volatility and risk, RVP or CUPR?

Which has better earnings & valuation, RVP or CUPR?

Do analysts prefer RVP or CUPR?

Do insiders and institutionals believe in RVP or CUPR?

Is RVP or CUPR more profitable?

Does the media refer more to RVP or CUPR?

Summary

How does Cuprina Holdings (Cayman) compare to Innovative Eyewear?

Which has more risk & volatility, CUPR or LUCY?

Is CUPR or LUCY more profitable?

Do institutionals & insiders have more ownership in CUPR or LUCY?

Do analysts prefer CUPR or LUCY?

Does the media favor CUPR or LUCY?

Which has stronger earnings and valuation, CUPR or LUCY?

Summary

How does Cuprina Holdings (Cayman) compare to Biomerica?

Does the media prefer BMRA or CUPR?

Which has more volatility & risk, BMRA or CUPR?

Do insiders & institutionals hold more shares of BMRA or CUPR?

Do analysts prefer BMRA or CUPR?

Is BMRA or CUPR more profitable?

Which has preferable valuation and earnings, BMRA or CUPR?

Summary

Media Sentiment Over Time

CUPR vs. The Competition

Cuprina Holdings (Cayman) Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools